News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Gilead Sciences, Inc. Says U.S. Upholds One Viread Patent
May 21, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LOS ANGELES, May 20 (Reuters) - Gilead Sciences Inc said on Tuesday that U.S. patent officials have upheld one of the four challenged patents covering its AIDS medicine Viread.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Gilead Sciences, Inc.
MORE ON THIS TOPIC
Regulatory
HHS Backs Prasad Amid Moderna Flu Shot Blowback
February 12, 2026
·
2 min read
·
Tristan Manalac
Legal
AbbVie Sues HHS, CMS for Including Botox in Drug Price Negotiation Program
February 12, 2026
·
1 min read
·
Tristan Manalac
GLP-1
Novo Sues Hims & Hers Over Compounded Version of Oral Wegovy Pill
February 9, 2026
·
2 min read
·
Tristan Manalac
Opinion
2025 Reshaped the FDA. What Will 2026 Hold?
February 9, 2026
·
6 min read
·
Claire Davies
